News Conference News ACC 2023 AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup L.A. McKeown March 09, 2023
News Conference News ACC 2023 Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2 Michael O'Riordan March 09, 2023
News Conference News ACC 2023 Wrist-Worn Sensor May Help Detect Elevated Troponin in ACS L.A. McKeown March 06, 2023
News Conference News ACC 2023 BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF L.A. McKeown March 06, 2023
News Conference News ACC 2023 No Downside to Immediate Complete Revascularization in ACS: BIOVASC Michael O'Riordan March 06, 2023
Presentation ACC 2023 Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease Presenter: Roberto Diletti March 05, 2023
News Conference News ACC 2023 Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes Michael O'Riordan March 04, 2023
News Daily News Worse CABG Outcomes in Women Haven’t Budged in Over a Decade: STS L.A. McKeown March 03, 2023
News Daily News New Data Support Tighter Air Pollution Standards to Reduce CV Events L.A. McKeown February 27, 2023
News Daily News In COVID-19 Patients, Vaccination Linked to Lower MACE Risk Michael O'Riordan February 22, 2023
News Daily News Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men Yael L. Maxwell February 21, 2023
News Daily News Longer-Term ASCVD Risk Assessment Best for Younger Patients Michael O'Riordan February 16, 2023
News Daily News Risk of Sports-Related Sudden Cardiac Arrest Low in Older Adults Michael O'Riordan February 09, 2023
News Daily News Prehospital Troponin Testing With EMS Input Could Save a Lot of Money Michael O'Riordan February 07, 2023
News Daily News Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis L.A. McKeown February 02, 2023
News Daily News UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy Michael O'Riordan January 20, 2023
News Daily News Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3 Michael O'Riordan January 16, 2023
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023